A Randomized Trial to Evaluate the Sustained Efficacy of a Mucus Clearance Device in Ambulatory Patients with Chronic Obstructive Pulmonary Disease

OBJECTIVE: To determine whether a mucus clearance device (MCD) (Flutter; Axcan Scandipharm, USA) could consistently improve the bronchodilator response and exercise performance in patients with chronic obstructive pulmonary disease (COPD) when used in an ambulatory setting over a one-week period.

Bibliographic Details
Main Authors: Norman Wolkove, Marc A Baltzan, Hany Kamel, Michael Rotaple
Format: Article
Language:English
Published: Hindawi Limited 2004-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2004/828591